Literature DB >> 21269571

Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population.

Qingrui Yang1, Yi Liu, Dongxia Liu, Yuanchao Zhang, Kun Mu.   

Abstract

OBJECTIVES: To investigate the association of the polymorphisms and haplotypes in the PD-1 and PD-1 ligand genes with ankylosing spondylitis (AS) in a Chinese population.
METHODS: A total of 196 Chinese patients with ankylosing spondylitis and 180 age- and sex-matched controls of the same ethnic origin were included in the study. The polymorphisms in PD-1 and PD-1 ligand genes were genotyped using polymerase chain reaction-restriction fragment length polymorphism, allele-specific PCR and fluorescence melting curve methods.
RESULTS: The T allele of the PD-1 rs2227982 polymorphism was more frequent in the patient group than in the controls (28.53% vs. 17.22%; p=0.000). The frequency of the CT haplotype (PD-1 rs2227981 C allele and PD-1 rs2227982 T allele) was higher in the AS patient group comparing with the controls (odds ratio (OR)=1.845, 95% confidence interval 1.220-2.789). The C allele of the PD-L1 rs822336 polymorphism was also more frequent in the patients than in the controls (34.69% vs. 27.22%; p=0.007). However, we did not find any evidence of genetic association between PD-L2 rs1009759/rs6476985 polymorphisms and AS (p=0.371 and 0.061, respectively). No significant difference in the distribution of the PD-1 rs2227981 alleles was found in our population when comparing AS patients with control groups (p=0.226).
CONCLUSIONS: The results support a major role for PD-1/PD-L1 polymorphisms in disease susceptibility of AS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269571

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review.

Authors:  Si Chen; Yuan Li; Chuiwen Deng; Jing Li; Xiaoting Wen; Ziyan Wu; Chaojun Hu; Shulan Zhang; Ping Li; Xuan Zhang; Fengchun Zhang; Yongzhe Li
Journal:  Rheumatol Int       Date:  2015-08-01       Impact factor: 2.631

Review 2.  Meta-analysis of genetic polymorphisms in programmed cell death 1. Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility.

Authors:  Y H Lee; S-C Bae; J-H Kim; G G Song
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

3.  Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome.

Authors:  Rui Han; Xiaoyun Gong; Yuejie Zhu; Xiaoran Liu; Yan Xia; Yuhong Huang; Meng Zhang; Yunian Zhang; Xiaolin La; Jianbing Ding
Journal:  Biomed Res Int       Date:  2021-01-04       Impact factor: 3.411

4.  Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.

Authors:  Nghiem Xuan Hoan; Pham Thi Minh Huyen; Mai Thanh Binh; Ngo Tat Trung; Dao Phuong Giang; Bui Thuy Linh; Dang Thi Ngoc Dung; Srinivas Reddy Pallerla; Peter G Kremsner; Thirumalaisamy P Velavan; Mai Hong Bang; Le Huu Song
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

5.  PD-L1 rs2890658 Polymorphism Increases Risk for Non-Small-Cell Lung Cancer in Northern China Population Based on Experimental Data and Meta-Analysis.

Authors:  Guigang Wang; Yuehua Dong; Yanjun Yang; Wenjing Zhang; Na Liu; Yulei Wei
Journal:  Contrast Media Mol Imaging       Date:  2022-08-02       Impact factor: 3.009

6.  Pilot Study: Immune Checkpoints Polymorphisms in Greek Primary Breast Cancer Patients.

Authors:  Nyanbol Kuol; Xu Yan; Vanessa Barriga; Jimsheena Karakkat; Stamatis Vassilaros; Ioannis Fyssas; Anastasios Tsimpanis; Sarah Fraser; Kulmira Nurgali; Vasso Apostolopoulos
Journal:  Biomedicines       Date:  2022-07-29

7.  Ankylosing spondylitis: from cells to genes.

Authors:  José Francisco Zambrano-Zaragoza; Juan Manuel Agraz-Cibrian; Christian González-Reyes; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2013-07-21

8.  Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab.

Authors:  Tomoko Yamamoto Funazo; Takashi Nomizo; Hiroaki Ozasa; Takahiro Tsuji; Yuto Yasuda; Hironori Yoshida; Yuichi Sakamori; Hiroki Nagai; Toyohiro Hirai; Young Hak Kim
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.